The Discounted Cash Flow (DCF) valuation of Acorda Therapeutics Inc (ACOR) is (76.74) USD. With the latest stock price at 0.01 USD, the upside of Acorda Therapeutics Inc based on DCF is -568553.5%.
Based on the latest price of 0.01 USD and our DCF valuation, Acorda Therapeutics Inc (ACOR) is a sell. selling ACOR stocks now will result in a potential gain of 568553.5%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 4.3% - 7.6% | 5.9% |
| Long-term Growth Rate | 3.0% - 4.0% | 3.5% |
| Fair Price | (707.93) - (42.09) | (76.74) |
| Upside | -5244040.4% - -311905.9% | -568553.5% |